TARDBP and amyotrophic lateral sclerosis: This targeted mass spectrometry approach holds promise for identifying a comprehensive set of TDP-43 cryptic targets and other proteomic changes occurring during early stages of ALS, and for defining the natural history of familial ALS [136].